FORA Capital LLC Buys Shares of 34,892 Teleflex Incorporated $TFX

Key Points

• FORA Capital LLC invested approximately $4.82 million in Teleflex Incorporated by acquiring 34,892 shares, representing a 0.08% stake in the company.
• Teleflex reported $3.73 earnings per share for the last quarter, exceeding analyst expectations of $3.36, along with a revenue of $780.90 million, which was up 4.2% from the previous year.
• The company recently declared a quarterly dividend of $0.34, with a dividend yield of 1.1% and a payout ratio of 32.00%.

FORA Capital LLC purchased a new position in Teleflex Incorporated (NYSE:TFX - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 34,892 shares of the medical technology company's stock, valued at approximately $4,822,000. FORA Capital LLC owned 0.08% of Teleflex at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Dimensional Fund Advisors LP boosted its position in Teleflex by 69.5% during the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock worth $119,927,000 after purchasing an additional 355,720 shares in the last quarter. Diamond Hill Capital Management Inc. raised its stake in shares of Teleflex by 122.8% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock worth $80,784,000 after buying an additional 322,222 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of Teleflex by 229.9% in the 1st quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company's stock worth $31,856,000 after buying an additional 160,646 shares in the last quarter. Deutsche Bank AG increased its holdings in Teleflex by 62.5% during the 4th quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock valued at $72,461,000 after acquiring an additional 156,524 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its stake in shares of Teleflex by 2,440.9% during the 1st quarter. Public Sector Pension Investment Board now owns 147,298 shares of the medical technology company's stock worth $20,355,000 after purchasing an additional 141,501 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Liam Kelly acquired 1,500 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average cost of $115.07 per share, with a total value of $172,605.00. Following the completion of the acquisition, the chief executive officer directly owned 45,267 shares in the company, valued at $5,208,873.69. This represents a 3.43% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jaewon Ryu bought 1,500 shares of Teleflex stock in a transaction on Tuesday, August 5th. The shares were purchased at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the acquisition, the director owned 3,727 shares in the company, valued at $428,605. The trade was a 67.36% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by insiders.

Teleflex Stock Down 2.5%

TFX traded down $3.22 during trading hours on Thursday, reaching $126.28. 436,361 shares of the stock traded hands, compared to its average volume of 586,802. The firm's fifty day simple moving average is $118.88 and its two-hundred day simple moving average is $129.69. The company has a market cap of $5.58 billion, a price-to-earnings ratio of 29.71, a PEG ratio of 1.81 and a beta of 1.08. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.41 and a quick ratio of 1.44.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The firm had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The firm's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be given a dividend of $0.34 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Analysts Set New Price Targets

TFX has been the subject of several analyst reports. Truist Financial cut their target price on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a research note on Monday, May 5th. Mizuho upped their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Royal Bank Of Canada upped their price target on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research note on Friday, August 1st. Morgan Stanley dropped their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research report on Monday, May 5th. Finally, Wells Fargo & Company cut their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Teleflex presently has an average rating of "Hold" and a consensus price target of $141.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.